Citigroup »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Citigroup

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.5M 8.0M 1.19
2024-03-31 $220k 226k 0.97
2023-12-31 $993k 1.1M 0.93
2023-09-30 $51k 55k 0.93

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1